Ignite Creation Date:
2025-12-24 @ 9:23 PM
Ignite Modification Date:
2026-01-01 @ 6:26 AM
Study NCT ID:
NCT01451632
Status:
COMPLETED
Last Update Posted:
2016-09-08
First Post:
2011-10-07
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Safety Study of MM-121 With Cetuximab and Irinotecan in Patients With Advanced Cancers
Sponsor:
Merrimack Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
MM-121-05-01-05 (TCD11696)
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |